S&P 500   2,742.82 (+3.14%)
DOW   23,375.13 (+3.18%)
QQQ   200.30 (+1.99%)
AAPL   266.01 (+2.54%)
FB   173.69 (+2.88%)
GOOGL   1,208.91 (+2.23%)
AMZN   2,034.45 (+1.14%)
CGC   15.06 (+3.86%)
NVDA   267.18 (+3.15%)
BABA   195.02 (-1.51%)
MU   48.31 (+3.80%)
GE   7.29 (+3.70%)
TSLA   545.86 (+0.08%)
AMD   48.68 (+2.33%)
T   29.55 (-1.89%)
ACB   0.85 (+6.22%)
F   5.00 (+6.16%)
NFLX   370.13 (-0.58%)
BAC   23.24 (+4.92%)
DIS   100.60 (-0.63%)
PRI   96.85 (+9.98%)
S&P 500   2,742.82 (+3.14%)
DOW   23,375.13 (+3.18%)
QQQ   200.30 (+1.99%)
AAPL   266.01 (+2.54%)
FB   173.69 (+2.88%)
GOOGL   1,208.91 (+2.23%)
AMZN   2,034.45 (+1.14%)
CGC   15.06 (+3.86%)
NVDA   267.18 (+3.15%)
BABA   195.02 (-1.51%)
MU   48.31 (+3.80%)
GE   7.29 (+3.70%)
TSLA   545.86 (+0.08%)
AMD   48.68 (+2.33%)
T   29.55 (-1.89%)
ACB   0.85 (+6.22%)
F   5.00 (+6.16%)
NFLX   370.13 (-0.58%)
BAC   23.24 (+4.92%)
DIS   100.60 (-0.63%)
PRI   96.85 (+9.98%)
S&P 500   2,742.82 (+3.14%)
DOW   23,375.13 (+3.18%)
QQQ   200.30 (+1.99%)
AAPL   266.01 (+2.54%)
FB   173.69 (+2.88%)
GOOGL   1,208.91 (+2.23%)
AMZN   2,034.45 (+1.14%)
CGC   15.06 (+3.86%)
NVDA   267.18 (+3.15%)
BABA   195.02 (-1.51%)
MU   48.31 (+3.80%)
GE   7.29 (+3.70%)
TSLA   545.86 (+0.08%)
AMD   48.68 (+2.33%)
T   29.55 (-1.89%)
ACB   0.85 (+6.22%)
F   5.00 (+6.16%)
NFLX   370.13 (-0.58%)
BAC   23.24 (+4.92%)
DIS   100.60 (-0.63%)
PRI   96.85 (+9.98%)
S&P 500   2,742.82 (+3.14%)
DOW   23,375.13 (+3.18%)
QQQ   200.30 (+1.99%)
AAPL   266.01 (+2.54%)
FB   173.69 (+2.88%)
GOOGL   1,208.91 (+2.23%)
AMZN   2,034.45 (+1.14%)
CGC   15.06 (+3.86%)
NVDA   267.18 (+3.15%)
BABA   195.02 (-1.51%)
MU   48.31 (+3.80%)
GE   7.29 (+3.70%)
TSLA   545.86 (+0.08%)
AMD   48.68 (+2.33%)
T   29.55 (-1.89%)
ACB   0.85 (+6.22%)
F   5.00 (+6.16%)
NFLX   370.13 (-0.58%)
BAC   23.24 (+4.92%)
DIS   100.60 (-0.63%)
PRI   96.85 (+9.98%)
Log in

LON:ERGOErgomed Share Price, Forecast & News

GBX 453
-2.50 (-0.55 %)
(As of 04/8/2020 02:58 PM ET)
Add
Compare
Today's Range
446
Now: GBX 453
464
50-Day Range
280
MA: GBX 396.47
455.50
52-Week Range
165
Now: GBX 453
478
Volume28,294 shs
Average Volume28,490 shs
Market Capitalization£218.15 million
P/E Ratio39.39
Dividend YieldN/A
BetaN/A
Ergomed plc provides clinical research, and drug development and safety and medical information services in the United Kingdom and internationally. The company offers clinical development, trial management, and pharmacovigilance services for pharmaceutical and generics companies, as well as small and mid-sized drug development companies. It focuses on various therapeutic areas, including oncology, neurology, and immunology, as well as the development of orphan drugs. The company also provides services include project management, monitoring, site management, safety, regulatory and quality management, clinical data management and biostatistics, and medical writing. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.
Read More
Ergomed logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.52 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1483-503205

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£68.26 million
Cash FlowGBX 35.08 per share
Book ValueGBX 77.90 per share

Profitability

Miscellaneous

Employees700
Market Cap£218.15 million
Next Earnings DateN/A
OptionableNot Optionable

Receive ERGO News and Ratings via Email

Sign-up to receive the latest news and ratings for ERGO and its competitors with MarketBeat's FREE daily newsletter.


Ergomed (LON:ERGO) Frequently Asked Questions

How has Ergomed's stock been impacted by COVID-19 (Coronavirus)?

Ergomed's stock was trading at GBX 392 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ERGO shares have increased by 15.6% and is now trading at GBX 453. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Ergomed?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ergomed in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Ergomed.

How were Ergomed's earnings last quarter?

Ergomed PLC (LON:ERGO) announced its earnings results on Monday, September, 18th. The company reported $1.20 earnings per share (EPS) for the quarter. The firm had revenue of $22.91 million for the quarter. View Ergomed's earnings history.

What price target have analysts set for ERGO?

1 brokerages have issued 12-month price targets for Ergomed's shares. Their forecasts range from GBX 267 to GBX 267. On average, they anticipate Ergomed's stock price to reach GBX 267 in the next year. This suggests that the stock has a possible downside of 41.1%. View analysts' price targets for Ergomed.

Has Ergomed been receiving favorable news coverage?

Media coverage about ERGO stock has been trending very negative on Wednesday, according to InfoTrie Sentiment. The research firm ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Ergomed earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutErgomed.

Who are some of Ergomed's key competitors?

What other stocks do shareholders of Ergomed own?

Who are Ergomed's key executives?

Ergomed's management team includes the following people:
  • Dr. Miroslav Reljanovic, Founder & Exec. Chairman (Age 60)
  • Dr. Jan Petracek, COO & Director (Age 43)
  • Mr. Stuart Robert Jackson, CFO & Director (Age 59)
  • Ms. Sanja Juric, Gen. Counsel & Company Sec.
  • Dr. Michael Forstner, Head of Risk Management & Pharmacoepidemiology

What is Ergomed's stock symbol?

Ergomed trades on the London Stock Exchange (LON) under the ticker symbol "ERGO."

How do I buy shares of Ergomed?

Shares of ERGO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Ergomed's stock price today?

One share of ERGO stock can currently be purchased for approximately GBX 453.

How big of a company is Ergomed?

Ergomed has a market capitalization of £218.15 million and generates £68.26 million in revenue each year. Ergomed employs 700 workers across the globe. View additional information about Ergomed.

What is Ergomed's official website?

The official website for Ergomed is http://www.ergomedplc.com/.

How can I contact Ergomed?

Ergomed's mailing address is 26-24 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The company can be reached via phone at +44-1483-503205.

This page was last updated on 4/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel